Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
University of Pittsburgh
University of Pittsburgh
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Intensity Therapeutics, Inc.
ETOP IBCSG Partners Foundation
NYU Langone Health
Ludwig Institute for Cancer Research
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins